Stock Research for APRI

APRI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

APRI Stock Chart & Research Data

The APRI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APRI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APRI Due diligence Resources & Stock Charts

The APRI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APRI Detailed Price Forecast - CNN Money CNN View APRI Detailed Summary - Google Finance
Yahoo View APRI Detailed Summary - Yahoo! Finance Zacks View APRI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View APRI Trends & Analysis - Trade-Ideas Barrons View APRI Major Holders - Barrons
NASDAQ View APRI Call Transcripts - NASDAQ Seeking View APRI Breaking News & Analysis - Seeking Alpha
Spotlight View APRI Annual Report - CompanySpotlight.com OTC Report View APRI OTC Short Report - OTCShortReport.com
TradeKing View APRI Fundamentals - TradeKing Charts View APRI SEC Filings - Bar Chart
WSJ View Historical Prices for APRI - The WSJ Morningstar View Performance/Total Return for APRI - Morningstar
MarketWatch View the Analyst Estimates for APRI - MarketWatch CNBC View the Earnings History for APRI - CNBC
StockMarketWatch View the APRI Earnings - StockMarketWatch MacroAxis View APRI Buy or Sell Recommendations - MacroAxis
Bullish View the APRI Bullish Patterns - American Bulls Short Pains View APRI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View APRI Stock Mentions - StockTwits PennyStocks View APRI Stock Mentions - PennyStockTweets
Twitter View APRI Stock Mentions - Twitter Invest Hub View APRI Investment Forum News - Investor Hub
Yahoo View APRI Stock Mentions - Yahoo! Message Board Seeking Alpha View APRI Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for APRI - SECform4.com Insider Cow View Insider Transactions for APRI - Insider Cow
CNBC View APRI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APRI - OTC Markets
Yahoo View Insider Transactions for APRI - Yahoo! Finance NASDAQ View Institutional Holdings for APRI - NASDAQ


Stock Charts

FinViz View APRI Stock Insight & Charts - FinViz.com StockCharts View APRI Investment Charts - StockCharts.com
BarChart View APRI Stock Overview & Charts - BarChart Trading View View APRI User Generated Charts - Trading View


Latest Financial News for APRI

Benzinga Pro's 5 Stocks To Watch Today
Posted on Monday April 16, 2018

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Netflix, Inc. (NASDAQ: NFLX ) stock was trading higher ...


Apricus mulls options; to sell U.S. rights to Vitaros
Posted on Monday April 16, 2018

Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product. Shares of the company fell 24 percent to 32 cents in premarket trading, valuing the company at $7.5 million.


FDA asks for new formulation of Apricus' erectile dysfunction cream
Posted on Monday April 16, 2018

Drugmaker Apricus Biosciences Inc said on Monday the U.S. regulator directed it to develop a new formulation for its erectile dysfunction cream, Vitaros, which was rejected in February. The U.S. Food And ...


Apricus Biosciences Announces Outcome of Vitaros(TM) End-of-Review Meeting with FDA
Posted on Monday April 16, 2018

FDA Confirms Vitaros Regulatory Pathway  Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, ...


Enter a stock symbol to view the stock details.